CLGN · CollPlant Biotechnologies Ltd
United States · RS rating 99 · As of 2026-11-03
| Price | 4.11 USD |
|---|---|
| 1-day change | +0.7% |
| RS rating (overall / 1M / 3M / 12M) | 99 / 94 / 99 / 93 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 36 / 79 / 47 |
| Industry group (rank) | Medical-Systems/Equip (86) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -22.1% |
| Distance from 52-week high | +9.9% |
| Market cap (USD) | $5.1M |